Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Samantha Barton"'
Autor:
Steven J Edwards, Charlotta Karner, Tracey Jhita, Samantha Barton, Gemma Marceniuk, Zenas Z N Yiu, Miriam Wittmann
Publikováno v:
Health Technology Assessment, Vol 28, Iss 04 (2024)
Background Atopic dermatitis is a chronic relapsing inflammatory skin condition. One of the most common skin disorders in children, atopic dermatitis typically manifests before the age of 5 years, but it can develop at any age. Atopic dermatitis is c
Externí odkaz:
https://doaj.org/article/1274ca3c50664411bbcdcb771f3d276b
Autor:
Steven J Edwards, Samantha Barton, Mariana Bacelar, Charlotta Karner, Peter Cain, Victoria Wakefield, Gemma Marceniuk
Publikováno v:
Health Technology Assessment, Vol 25, Iss 23 (2021)
Background: Crohn’s disease is a lifelong condition that can affect any segment of the gastrointestinal tract. Some people with Crohn’s disease may be at higher risk of following a severe course of disease than others and being able to identify t
Externí odkaz:
https://doaj.org/article/ad4896cee2634893928a51b5ddf5c856
Autor:
Binod Kumar, Samantha Barton, Jolanta Kordowska, Roger B. Eaton, Anne M. Counihan, Jaime E. Hale, Anne Marie Comeau
Publikováno v:
International Journal of Neonatal Screening, Vol 7, Iss 3, p 47 (2021)
Promising treatments for spinal muscular atrophy (SMA), the leading genetic cause of infant mortality, prompted calls for inclusion in newborn screening (NBS). In January 2018, the New England Newborn Screening Program (NENSP) began statewide screeni
Externí odkaz:
https://doaj.org/article/6495c041efc244bb87c9bb915838ab5b
Publikováno v:
Health Technology Assessment, Vol 20, Iss 24 (2016)
Background: Typically occurring on the external genitalia, anogenital warts (AGWs) are benign epithelial skin lesions caused by human papillomavirus infection. AGWs are usually painless but can be unsightly and physically uncomfortable, and affected
Externí odkaz:
https://doaj.org/article/ffe099b372074fc484bc81e87428d490
Publikováno v:
Health Technology Assessment, Vol 19, Iss 7 (2015)
Background: Ovarian cancer is the fifth most common cancer in the UK, and the fourth most common cause of cancer death. Of those people successfully treated with first-line chemotherapy, 55–75% will relapse within 2 years. At this time, it is uncer
Externí odkaz:
https://doaj.org/article/6b8991eca07a4a04a01f8261ac0ae2e8
Publikováno v:
Health Technology Assessment, Vol 18, Iss 50 (2014)
Background: Anxiety and related disorders include generalised anxiety disorder, obsessive–compulsive disorder, panic disorder, post-traumatic stress disorder and phobic disorders (intense fear of an object or situation). These disorders share the p
Externí odkaz:
https://doaj.org/article/702053c80744410f80ef172178db4fec
Publikováno v:
Clinical Psychology Forum. 1:61-67
The BPS Pre-Qualification Group (PQG) have completed a project looking into the experiences of pre-qualified psychologists attending aspiring psychologist groups. The aim of this paper is to share these findings with the hope of; raising awareness ab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e62950451ab8899341fb970d4ff46c6b
https://doi.org/10.53841/bpscpf.2021.1.338.61
https://doi.org/10.53841/bpscpf.2021.1.338.61
Autor:
Anne Marie Comeau, Binod Kumar, Roger B. Eaton, Anne M. Counihan, Samantha Barton, Jaime E. Hale, Jolanta Kordowska
Publikováno v:
International Journal of Neonatal Screening
International Journal of Neonatal Screening, Vol 7, Iss 47, p 47 (2021)
Volume 7
Issue 3
International Journal of Neonatal Screening, Vol 7, Iss 47, p 47 (2021)
Volume 7
Issue 3
Promising treatments for spinal muscular atrophy (SMA), the leading genetic cause of infant mortality, prompted calls for inclusion in newborn screening (NBS). In January 2018, the New England Newborn Screening Program (NENSP) began statewide screeni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::701b1e30de9eab2802f45895ea3b5a24
http://europepmc.org/articles/PMC8395917
http://europepmc.org/articles/PMC8395917
Autor:
Samantha Barton, Charlotta Karner, Victoria Wakefield, Peter Cain, Gemma Marceniuk, Mariana Bacelar, Steven J Edwards
Publikováno v:
Health Technol Assess
Health Technology Assessment, Vol 25, Iss 23 (2021)
Health Technology Assessment, Vol 25, Iss 23 (2021)
Background Crohn’s disease is a lifelong condition that can affect any segment of the gastrointestinal tract. Some people with Crohn’s disease may be at higher risk of following a severe course of disease than others and being able to identify th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7d487862a186788da4e0e78b138293a
https://pubmed.ncbi.nlm.nih.gov/33783345
https://pubmed.ncbi.nlm.nih.gov/33783345
As part of its Single Technology Appraisal (STA) process, the UK National Institute for Health and Care Excellence (NICE) invited the manufacturer (EUSA Pharma) of dinutuximab beta (Qarziba®) to submit evidence of its clinical and cost effectiveness
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37e58ca28618d11de1d5e86ff405f528
